Close
CDMO Safety Testing 2026
Novotech

Press Releases

Chemspec Europe 2026 Draws Global Industry Participation

Chemspec Europe returned to Cologne on 6โ€“7 May 2026, bringing together professionals from across the speciality chemicals sector despite ongoing economic and regulatory challenges facing the industry. The event welcomed 4,238 attendees representing 60 nations and featured 454 exhibitors...

eschbach Unveils Seqonis Intelligent Operations Platform

eschbach has renamed its flagship enterprise software platform, Shiftconnector, to Seqonis, marking a new phase in the productโ€™s development after two decades of expansion across pharmaceutical, chemical and process manufacturing industries. The announcement was made during the Pharma Manufacturing...

Agilent, Veeda Lifesciences Launch Biopharma Analytics Hub

Agilent Technologies and Veeda Lifesciences have announced a strategic collaboration aimed at strengthening regulatory-aligned analytical and bioanalytical workflows for biopharma development as GLP-1 and other advanced therapeutic modalities continue to progress across global pipelines. The partnership will combine Agilentโ€™s...

Shilpa Medicare, NXI Therapeutics AG Enters Partnership

A long-term development and commercial manufacturing agreement has been signed between Shilpa Medicare Limited and Switzerland-based NXI Therapeutics AG, extending the Indian pharmaceutical companyโ€™s role in global biologics and specialty therapeutics manufacturing. The agreement covers comprehensive chemistry, manufacturing and...

Cantex and Headlamp Target MS Depression Using Lumos AI

Cantex Pharmaceuticals and Headlamp Health have entered a collaboration aimed at advancing the clinical development of azeliragon for the treatment of severe depression and fatigue in patients with multiple sclerosis (MS). Through the agreement, Cantex and Headlamp will apply...

VoxCell and adMare Partner on Antibody Therapy Research

VoxCell BioInnovation Inc. and adMare BioInnovations have entered a research collaboration focused on assessing the scientific and commercial viability of a novel antibody-based immune-modulating therapy through the use of human-relevant vascularized cancer tissue models. The partnership will combine bioprinted...

Avenda Health Expands Unfold AI Into Midwest Cancer Care

Avenda Health said the University of Michigan Health Weiser Center for Prostate Cancer has become the first healthcare institution in the Midwest to implement its AI-based prostate cancer mapping technology, extending advanced imaging support into one of the countryโ€™s...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป